Erratum: The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder: Erratum

No authors listed

Published Erratum

No authors listed. Medicine (Baltimore). 2016.

. 2016 Oct 14;95(41):e651b.

doi: 10.1097/01.md.0000504574.73365.1b. eCollection 2016 Oct.

Abstract

[This corrects the article DOI: 10.1097/MD.0000000000003488.].

The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.
Chang TT, Chen SL, Chang YH, Chen PS, Chu CH, Chen SH, Huang SY, Tzeng NS, Wang LJ, Wang TY, Li CL, Chung YL, Hsieh TH, Lee IH, Chen KC, Yang YK, Hong JS, Lu RB, Lee SY. Chang TT, et al. Medicine (Baltimore). 2016 Jun;95(24):e3488. doi: 10.1097/MD.0000000000003488. Medicine (Baltimore). 2016. PMID: 27310943 Free PMC article. Clinical Trial.

1. Chang T-T, Chen S-L, Chang Y-H, et al. The DRD3 Ser9Gly polymorphism predicted metabolic change in drug-naive patients with bipolar II disorder. Medicine. 2016. 95:e3488. - PMC - PubMed